Evidence map›Paper›PMID 32520423›Full record

ArticleJournal of cellular and molecular medicine2020

Significance of neutrophil microparticles in ischaemia-reperfusion: Pro-inflammatory effectors of endothelial senescence and vascular dysfunction.

Ali El Habhab, Raed Altamimy, Malak Abbas, Mohamad Kassem, Lamia Amoura, Abdul Wahid Qureshi, Hanine El Itawi, Guillaume Kreutter, Sonia Khemais-Benkhiat, Fatiha Zobairi and 3 more

Open access · goldAbstract read
In one paragraph

Article in Journal of cellular and molecular medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.6field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 11 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Extracellular Vesicles and Vascular Inflammation.Advances in experimental medicine and biology · 2023
    Article
  5. Review
  6. Review
  7. Review
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 1 country.

Ali El HabhabINSERM (French National Institute of Health and Medical Research), UMR 1260, Regenerative Nanomedicine (RNM), University of Strasbourg, Illkirch-Graffenstaden, France.ORCID 0000-0001-7299-1892
Raed AltamimyINSERM (French National Institute of Health and Medical Research), UMR 1260, Regenerative Nanomedicine (RNM), University of Strasbourg, Illkirch-Graffenstaden, France.
Malak AbbasUMR CNRS 7213, Laboratory of Biophotonics and Pharmacology, Faculty of Pharmacy, University of Strasbourg, Illkirch-Graffenstaden, France.
Mohamad KassemINSERM (French National Institute of Health and Medical Research), UMR 1260, Regenerative Nanomedicine (RNM), University of Strasbourg, Illkirch-Graffenstaden, France.
Lamia AmouraINSERM (French National Institute of Health and Medical Research), UMR 1260, Regenerative Nanomedicine (RNM), University of Strasbourg, Illkirch-Graffenstaden, France.
Abdul Wahid QureshiINSERM (French National Institute of Health and Medical Research), UMR 1260, Regenerative Nanomedicine (RNM), University of Strasbourg, Illkirch-Graffenstaden, France.
Hanine El ItawiINSERM (French National Institute of Health and Medical Research), UMR 1260, Regenerative Nanomedicine (RNM), University of Strasbourg, Illkirch-Graffenstaden, France.
Guillaume KreutterINSERM (French National Institute of Health and Medical Research), UMR 1260, Regenerative Nanomedicine (RNM), University of Strasbourg, Illkirch-Graffenstaden, France.ORCID 0000-0002-6561-8384
Sonia Khemais-BenkhiatUMR CNRS 7213, Laboratory of Biophotonics and Pharmacology, Faculty of Pharmacy, University of Strasbourg, Illkirch-Graffenstaden, France.
Fatiha ZobairiINSERM (French National Institute of Health and Medical Research), UMR 1260, Regenerative Nanomedicine (RNM), University of Strasbourg, Illkirch-Graffenstaden, France.
Valérie B Schini-KerthINSERM (French National Institute of Health and Medical Research), UMR 1260, Regenerative Nanomedicine (RNM), University of Strasbourg, Illkirch-Graffenstaden, France.
Laurence KesslerINSERM (French National Institute of Health and Medical Research), UMR 1260, Regenerative Nanomedicine (RNM), University of Strasbourg, Illkirch-Graffenstaden, France.
Florence TotiINSERM (French National Institute of Health and Medical Research), UMR 1260, Regenerative Nanomedicine (RNM), University of Strasbourg, Illkirch-Graffenstaden, France.
Inserm · FRCentre National de la Recherche Scientifique · FRInternational Space University · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Endothelial senescence is an emerging cause of vascular dysfunction. Because microparticles are effectors of endothelial inflammation and vascular injury after ischaemia-reperfusion, we examined leucocyte-derived microparticles of spleen origin as possible contributors. Microparticles were generated from primary rat splenocytes by either lipopolysaccharide or phorbol-myristate-acetate/calcium ionophore, under conditions mimicking innate and adaptive immune responses. Incubation of primary porcine coronary endothelial cells with either type of microparticles, but not with those from unstimulated splenocytes, leads to a similar threefold raise in senescence-associated β-galactosidase activity within 48 hours, indicating accelerated senescence, to endothelial oxidative stress, and a fivefold and threefold increase in p21 and p16 senescence markers after 24 hours. After 12-hour incubation, the endothelial-dependent relaxation of coronary artery rings was reduced by 50%, at distinct optimal microparticle concentration. In vitro, microparticles were pro-thrombotic by up-regulating the local angiotensin system, by prompting tissue factor activity and a secondary generation of pro-coagulant endothelial microparticles. They initiated an early pro-inflammatory response by inducing phosphorylation of NF-κB, MAP kinases and Akt after 1 hour, and up-regulated VCAM-1 and ICAM-1 at 24 hours. Accordingly, VCAM-1 and COX-2 were also up-regulated in the coronary artery endothelium and eNOS down-regulated. Lipopolysaccharide specifically favoured the shedding of neutrophil- and monocyte-derived microparticles. A 80% immuno-depletion of neutrophil microparticles reduced endothelial senescence by 55%, indicating a key role. Altogether, data suggest that microparticles from activated splenocytes prompt early pro-inflammatory, pro-coagulant and pro-senescent responses in endothelial cells through redox-sensitive pathways. The control of neutrophil shedding could preserve the endothelium at site of ischaemia-reperfusion-driven inflammation and delay its dysfunction.

Indexed as

Cellular SenescenceAngiotensinsAnimalsApoptosisBlood CoagulationCell-Derived MicroparticlesCell LineageCyclooxygenase 2Endothelial CellsEndothelium, VascularInflammationLipopolysaccharidesMaleMAP Kinase Signaling SystemMonocytesNeutrophilsAngiotensinsCyclooxygenase 2LipopolysaccharidesNF-kappa BPhosphatidylinositol 3-KinasesTetradecanoylphorbol AcetateThromboplastinVascular Cell Adhesion Molecule-1endothelial senescenceinflammationischaemia-reperfusionmicroparticlestransplantationvascular dysfunction

Identifiers

PMID32520423
PMCPMC7339165
OpenAlexW3033677516

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.